0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Clinical Safety and Pharmacovigilance Services Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-17W18250
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Clinical Safety and Pharmacovigilance Services Market Research Report 2024
BUY CHAPTERS

Global Clinical Safety and Pharmacovigilance Services Market Research Report 2024

Code: QYRE-Auto-17W18250
Report
August 2024
Pages:138
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Clinical Safety and Pharmacovigilance Services Market

Clinical Safety and Pharmacovigilance Services encompass the processes and activities dedicated to ensuring the safety of pharmaceutical products and medical devices throughout their lifecycle. This includes monitoring and managing adverse events during clinical trials, post-marketing surveillance, signal detection, risk-benefit assessments, and compliance with regulatory requirements. These services aim to protect patients, maintain product integrity, and ensure adherence to safety regulations by identifying, assessing, and mitigating potential risks associated with medical treatments.
The global Clinical Safety and Pharmacovigilance Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Clinical Safety and Pharmacovigilance Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Clinical Safety and Pharmacovigilance Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Clinical Safety and Pharmacovigilance Services in Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Clinical Safety and Pharmacovigilance Services include SGS, PPD, ICON, IQVIA, Accenture, Syneos Health, Clarivate, Wipro, HCLTech, Medpace, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Clinical Safety and Pharmacovigilance Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Safety and Pharmacovigilance Services.
The Clinical Safety and Pharmacovigilance Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Safety and Pharmacovigilance Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Safety and Pharmacovigilance Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Clinical Safety and Pharmacovigilance Services Market Report

Report Metric Details
Report Name Clinical Safety and Pharmacovigilance Services Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company SGS, PPD, ICON, IQVIA, Accenture, Syneos Health, Clarivate, Wipro, HCLTech, Medpace, ProPharma, Lambda Therapeutic Research, PVpharm, George Clinical, PharmaLex, Parexel, CTI, UBC, Biomapas, Aixial Group, Worldwide Clinical Trials, Biotrial, PrimeVigilance, MMS Holdings, TransPerfect Life Sciences, Amarex, Precision for Medicine, Sitero, Medfiles, Arriello, TFS HealthScience, Pivotal, Quanticate, Veristat, WuXi AppTec, Tigermed
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Clinical Safety and Pharmacovigilance Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Clinical Safety and Pharmacovigilance Services Market report?

Ans: The main players in the Clinical Safety and Pharmacovigilance Services Market are SGS, PPD, ICON, IQVIA, Accenture, Syneos Health, Clarivate, Wipro, HCLTech, Medpace, ProPharma, Lambda Therapeutic Research, PVpharm, George Clinical, PharmaLex, Parexel, CTI, UBC, Biomapas, Aixial Group, Worldwide Clinical Trials, Biotrial, PrimeVigilance, MMS Holdings, TransPerfect Life Sciences, Amarex, Precision for Medicine, Sitero, Medfiles, Arriello, TFS HealthScience, Pivotal, Quanticate, Veristat, WuXi AppTec, Tigermed

What are the Application segmentation covered in the Clinical Safety and Pharmacovigilance Services Market report?

Ans: The Applications covered in the Clinical Safety and Pharmacovigilance Services Market report are Pharmaceutical Companies, Biotechnology Firms, Medical Device Manufacturers, Academic and Research Institutions, Others

What are the Type segmentation covered in the Clinical Safety and Pharmacovigilance Services Market report?

Ans: The Types covered in the Clinical Safety and Pharmacovigilance Services Market report are Clinical Study Safety Services, Post-Marketing Pharmacovigilance Services

Recommended Reports

Pharmacovigilance & Safety

Clinical Trials Services

Contract & CRO Services

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Safety and Pharmacovigilance Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Clinical Study Safety Services
1.2.3 Post-Marketing Pharmacovigilance Services
1.3 Market by Application
1.3.1 Global Clinical Safety and Pharmacovigilance Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Biotechnology Firms
1.3.4 Medical Device Manufacturers
1.3.5 Academic and Research Institutions
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Safety and Pharmacovigilance Services Market Perspective (2019-2030)
2.2 Global Clinical Safety and Pharmacovigilance Services Growth Trends by Region
2.2.1 Global Clinical Safety and Pharmacovigilance Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Clinical Safety and Pharmacovigilance Services Historic Market Size by Region (2019-2024)
2.2.3 Clinical Safety and Pharmacovigilance Services Forecasted Market Size by Region (2025-2030)
2.3 Clinical Safety and Pharmacovigilance Services Market Dynamics
2.3.1 Clinical Safety and Pharmacovigilance Services Industry Trends
2.3.2 Clinical Safety and Pharmacovigilance Services Market Drivers
2.3.3 Clinical Safety and Pharmacovigilance Services Market Challenges
2.3.4 Clinical Safety and Pharmacovigilance Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Safety and Pharmacovigilance Services Players by Revenue
3.1.1 Global Top Clinical Safety and Pharmacovigilance Services Players by Revenue (2019-2024)
3.1.2 Global Clinical Safety and Pharmacovigilance Services Revenue Market Share by Players (2019-2024)
3.2 Global Clinical Safety and Pharmacovigilance Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Clinical Safety and Pharmacovigilance Services Revenue
3.4 Global Clinical Safety and Pharmacovigilance Services Market Concentration Ratio
3.4.1 Global Clinical Safety and Pharmacovigilance Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Safety and Pharmacovigilance Services Revenue in 2023
3.5 Global Key Players of Clinical Safety and Pharmacovigilance Services Head office and Area Served
3.6 Global Key Players of Clinical Safety and Pharmacovigilance Services, Product and Application
3.7 Global Key Players of Clinical Safety and Pharmacovigilance Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Safety and Pharmacovigilance Services Breakdown Data by Type
4.1 Global Clinical Safety and Pharmacovigilance Services Historic Market Size by Type (2019-2024)
4.2 Global Clinical Safety and Pharmacovigilance Services Forecasted Market Size by Type (2025-2030)
5 Clinical Safety and Pharmacovigilance Services Breakdown Data by Application
5.1 Global Clinical Safety and Pharmacovigilance Services Historic Market Size by Application (2019-2024)
5.2 Global Clinical Safety and Pharmacovigilance Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Clinical Safety and Pharmacovigilance Services Market Size (2019-2030)
6.2 North America Clinical Safety and Pharmacovigilance Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Clinical Safety and Pharmacovigilance Services Market Size by Country (2019-2024)
6.4 North America Clinical Safety and Pharmacovigilance Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Safety and Pharmacovigilance Services Market Size (2019-2030)
7.2 Europe Clinical Safety and Pharmacovigilance Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Clinical Safety and Pharmacovigilance Services Market Size by Country (2019-2024)
7.4 Europe Clinical Safety and Pharmacovigilance Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Safety and Pharmacovigilance Services Market Size (2019-2030)
8.2 Asia-Pacific Clinical Safety and Pharmacovigilance Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Clinical Safety and Pharmacovigilance Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Clinical Safety and Pharmacovigilance Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Safety and Pharmacovigilance Services Market Size (2019-2030)
9.2 Latin America Clinical Safety and Pharmacovigilance Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Clinical Safety and Pharmacovigilance Services Market Size by Country (2019-2024)
9.4 Latin America Clinical Safety and Pharmacovigilance Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Safety and Pharmacovigilance Services Market Size (2019-2030)
10.2 Middle East & Africa Clinical Safety and Pharmacovigilance Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Clinical Safety and Pharmacovigilance Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Clinical Safety and Pharmacovigilance Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 SGS
11.1.1 SGS Company Details
11.1.2 SGS Business Overview
11.1.3 SGS Clinical Safety and Pharmacovigilance Services Introduction
11.1.4 SGS Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.1.5 SGS Recent Development
11.2 PPD
11.2.1 PPD Company Details
11.2.2 PPD Business Overview
11.2.3 PPD Clinical Safety and Pharmacovigilance Services Introduction
11.2.4 PPD Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.2.5 PPD Recent Development
11.3 ICON
11.3.1 ICON Company Details
11.3.2 ICON Business Overview
11.3.3 ICON Clinical Safety and Pharmacovigilance Services Introduction
11.3.4 ICON Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.3.5 ICON Recent Development
11.4 IQVIA
11.4.1 IQVIA Company Details
11.4.2 IQVIA Business Overview
11.4.3 IQVIA Clinical Safety and Pharmacovigilance Services Introduction
11.4.4 IQVIA Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.4.5 IQVIA Recent Development
11.5 Accenture
11.5.1 Accenture Company Details
11.5.2 Accenture Business Overview
11.5.3 Accenture Clinical Safety and Pharmacovigilance Services Introduction
11.5.4 Accenture Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.5.5 Accenture Recent Development
11.6 Syneos Health
11.6.1 Syneos Health Company Details
11.6.2 Syneos Health Business Overview
11.6.3 Syneos Health Clinical Safety and Pharmacovigilance Services Introduction
11.6.4 Syneos Health Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.6.5 Syneos Health Recent Development
11.7 Clarivate
11.7.1 Clarivate Company Details
11.7.2 Clarivate Business Overview
11.7.3 Clarivate Clinical Safety and Pharmacovigilance Services Introduction
11.7.4 Clarivate Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.7.5 Clarivate Recent Development
11.8 Wipro
11.8.1 Wipro Company Details
11.8.2 Wipro Business Overview
11.8.3 Wipro Clinical Safety and Pharmacovigilance Services Introduction
11.8.4 Wipro Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.8.5 Wipro Recent Development
11.9 HCLTech
11.9.1 HCLTech Company Details
11.9.2 HCLTech Business Overview
11.9.3 HCLTech Clinical Safety and Pharmacovigilance Services Introduction
11.9.4 HCLTech Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.9.5 HCLTech Recent Development
11.10 Medpace
11.10.1 Medpace Company Details
11.10.2 Medpace Business Overview
11.10.3 Medpace Clinical Safety and Pharmacovigilance Services Introduction
11.10.4 Medpace Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.10.5 Medpace Recent Development
11.11 ProPharma
11.11.1 ProPharma Company Details
11.11.2 ProPharma Business Overview
11.11.3 ProPharma Clinical Safety and Pharmacovigilance Services Introduction
11.11.4 ProPharma Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.11.5 ProPharma Recent Development
11.12 Lambda Therapeutic Research
11.12.1 Lambda Therapeutic Research Company Details
11.12.2 Lambda Therapeutic Research Business Overview
11.12.3 Lambda Therapeutic Research Clinical Safety and Pharmacovigilance Services Introduction
11.12.4 Lambda Therapeutic Research Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.12.5 Lambda Therapeutic Research Recent Development
11.13 PVpharm
11.13.1 PVpharm Company Details
11.13.2 PVpharm Business Overview
11.13.3 PVpharm Clinical Safety and Pharmacovigilance Services Introduction
11.13.4 PVpharm Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.13.5 PVpharm Recent Development
11.14 George Clinical
11.14.1 George Clinical Company Details
11.14.2 George Clinical Business Overview
11.14.3 George Clinical Clinical Safety and Pharmacovigilance Services Introduction
11.14.4 George Clinical Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.14.5 George Clinical Recent Development
11.15 PharmaLex
11.15.1 PharmaLex Company Details
11.15.2 PharmaLex Business Overview
11.15.3 PharmaLex Clinical Safety and Pharmacovigilance Services Introduction
11.15.4 PharmaLex Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.15.5 PharmaLex Recent Development
11.16 Parexel
11.16.1 Parexel Company Details
11.16.2 Parexel Business Overview
11.16.3 Parexel Clinical Safety and Pharmacovigilance Services Introduction
11.16.4 Parexel Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.16.5 Parexel Recent Development
11.17 CTI
11.17.1 CTI Company Details
11.17.2 CTI Business Overview
11.17.3 CTI Clinical Safety and Pharmacovigilance Services Introduction
11.17.4 CTI Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.17.5 CTI Recent Development
11.18 UBC
11.18.1 UBC Company Details
11.18.2 UBC Business Overview
11.18.3 UBC Clinical Safety and Pharmacovigilance Services Introduction
11.18.4 UBC Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.18.5 UBC Recent Development
11.19 Biomapas
11.19.1 Biomapas Company Details
11.19.2 Biomapas Business Overview
11.19.3 Biomapas Clinical Safety and Pharmacovigilance Services Introduction
11.19.4 Biomapas Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.19.5 Biomapas Recent Development
11.20 Aixial Group
11.20.1 Aixial Group Company Details
11.20.2 Aixial Group Business Overview
11.20.3 Aixial Group Clinical Safety and Pharmacovigilance Services Introduction
11.20.4 Aixial Group Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.20.5 Aixial Group Recent Development
11.21 Worldwide Clinical Trials
11.21.1 Worldwide Clinical Trials Company Details
11.21.2 Worldwide Clinical Trials Business Overview
11.21.3 Worldwide Clinical Trials Clinical Safety and Pharmacovigilance Services Introduction
11.21.4 Worldwide Clinical Trials Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.21.5 Worldwide Clinical Trials Recent Development
11.22 Biotrial
11.22.1 Biotrial Company Details
11.22.2 Biotrial Business Overview
11.22.3 Biotrial Clinical Safety and Pharmacovigilance Services Introduction
11.22.4 Biotrial Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.22.5 Biotrial Recent Development
11.23 PrimeVigilance
11.23.1 PrimeVigilance Company Details
11.23.2 PrimeVigilance Business Overview
11.23.3 PrimeVigilance Clinical Safety and Pharmacovigilance Services Introduction
11.23.4 PrimeVigilance Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.23.5 PrimeVigilance Recent Development
11.24 MMS Holdings
11.24.1 MMS Holdings Company Details
11.24.2 MMS Holdings Business Overview
11.24.3 MMS Holdings Clinical Safety and Pharmacovigilance Services Introduction
11.24.4 MMS Holdings Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.24.5 MMS Holdings Recent Development
11.25 TransPerfect Life Sciences
11.25.1 TransPerfect Life Sciences Company Details
11.25.2 TransPerfect Life Sciences Business Overview
11.25.3 TransPerfect Life Sciences Clinical Safety and Pharmacovigilance Services Introduction
11.25.4 TransPerfect Life Sciences Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.25.5 TransPerfect Life Sciences Recent Development
11.26 Amarex
11.26.1 Amarex Company Details
11.26.2 Amarex Business Overview
11.26.3 Amarex Clinical Safety and Pharmacovigilance Services Introduction
11.26.4 Amarex Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.26.5 Amarex Recent Development
11.27 Precision for Medicine
11.27.1 Precision for Medicine Company Details
11.27.2 Precision for Medicine Business Overview
11.27.3 Precision for Medicine Clinical Safety and Pharmacovigilance Services Introduction
11.27.4 Precision for Medicine Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.27.5 Precision for Medicine Recent Development
11.28 Sitero
11.28.1 Sitero Company Details
11.28.2 Sitero Business Overview
11.28.3 Sitero Clinical Safety and Pharmacovigilance Services Introduction
11.28.4 Sitero Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.28.5 Sitero Recent Development
11.29 Medfiles
11.29.1 Medfiles Company Details
11.29.2 Medfiles Business Overview
11.29.3 Medfiles Clinical Safety and Pharmacovigilance Services Introduction
11.29.4 Medfiles Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.29.5 Medfiles Recent Development
11.30 Arriello
11.30.1 Arriello Company Details
11.30.2 Arriello Business Overview
11.30.3 Arriello Clinical Safety and Pharmacovigilance Services Introduction
11.30.4 Arriello Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.30.5 Arriello Recent Development
11.31 TFS HealthScience
11.31.1 TFS HealthScience Company Details
11.31.2 TFS HealthScience Business Overview
11.31.3 TFS HealthScience Clinical Safety and Pharmacovigilance Services Introduction
11.31.4 TFS HealthScience Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.31.5 TFS HealthScience Recent Development
11.32 Pivotal
11.32.1 Pivotal Company Details
11.32.2 Pivotal Business Overview
11.32.3 Pivotal Clinical Safety and Pharmacovigilance Services Introduction
11.32.4 Pivotal Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.32.5 Pivotal Recent Development
11.33 Quanticate
11.33.1 Quanticate Company Details
11.33.2 Quanticate Business Overview
11.33.3 Quanticate Clinical Safety and Pharmacovigilance Services Introduction
11.33.4 Quanticate Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.33.5 Quanticate Recent Development
11.34 Veristat
11.34.1 Veristat Company Details
11.34.2 Veristat Business Overview
11.34.3 Veristat Clinical Safety and Pharmacovigilance Services Introduction
11.34.4 Veristat Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.34.5 Veristat Recent Development
11.35 WuXi AppTec
11.35.1 WuXi AppTec Company Details
11.35.2 WuXi AppTec Business Overview
11.35.3 WuXi AppTec Clinical Safety and Pharmacovigilance Services Introduction
11.35.4 WuXi AppTec Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.35.5 WuXi AppTec Recent Development
11.36 Tigermed
11.36.1 Tigermed Company Details
11.36.2 Tigermed Business Overview
11.36.3 Tigermed Clinical Safety and Pharmacovigilance Services Introduction
11.36.4 Tigermed Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
11.36.5 Tigermed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Clinical Safety and Pharmacovigilance Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Clinical Study Safety Services
 Table 3. Key Players of Post-Marketing Pharmacovigilance Services
 Table 4. Global Clinical Safety and Pharmacovigilance Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Clinical Safety and Pharmacovigilance Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Clinical Safety and Pharmacovigilance Services Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Clinical Safety and Pharmacovigilance Services Market Share by Region (2019-2024)
 Table 8. Global Clinical Safety and Pharmacovigilance Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Clinical Safety and Pharmacovigilance Services Market Share by Region (2025-2030)
 Table 10. Clinical Safety and Pharmacovigilance Services Market Trends
 Table 11. Clinical Safety and Pharmacovigilance Services Market Drivers
 Table 12. Clinical Safety and Pharmacovigilance Services Market Challenges
 Table 13. Clinical Safety and Pharmacovigilance Services Market Restraints
 Table 14. Global Clinical Safety and Pharmacovigilance Services Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Clinical Safety and Pharmacovigilance Services Market Share by Players (2019-2024)
 Table 16. Global Top Clinical Safety and Pharmacovigilance Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Safety and Pharmacovigilance Services as of 2023)
 Table 17. Ranking of Global Top Clinical Safety and Pharmacovigilance Services Companies by Revenue (US$ Million) in 2023
 Table 18. Global 5 Largest Players Market Share by Clinical Safety and Pharmacovigilance Services Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Clinical Safety and Pharmacovigilance Services, Headquarters and Area Served
 Table 20. Global Key Players of Clinical Safety and Pharmacovigilance Services, Product and Application
 Table 21. Global Key Players of Clinical Safety and Pharmacovigilance Services, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Clinical Safety and Pharmacovigilance Services Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Clinical Safety and Pharmacovigilance Services Revenue Market Share by Type (2019-2024)
 Table 25. Global Clinical Safety and Pharmacovigilance Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Clinical Safety and Pharmacovigilance Services Revenue Market Share by Type (2025-2030)
 Table 27. Global Clinical Safety and Pharmacovigilance Services Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Clinical Safety and Pharmacovigilance Services Revenue Market Share by Application (2019-2024)
 Table 29. Global Clinical Safety and Pharmacovigilance Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Clinical Safety and Pharmacovigilance Services Revenue Market Share by Application (2025-2030)
 Table 31. North America Clinical Safety and Pharmacovigilance Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 32. North America Clinical Safety and Pharmacovigilance Services Market Size by Country (2019-2024) & (US$ Million)
 Table 33. North America Clinical Safety and Pharmacovigilance Services Market Size by Country (2025-2030) & (US$ Million)
 Table 34. Europe Clinical Safety and Pharmacovigilance Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. Europe Clinical Safety and Pharmacovigilance Services Market Size by Country (2019-2024) & (US$ Million)
 Table 36. Europe Clinical Safety and Pharmacovigilance Services Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Asia-Pacific Clinical Safety and Pharmacovigilance Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Asia-Pacific Clinical Safety and Pharmacovigilance Services Market Size by Region (2019-2024) & (US$ Million)
 Table 39. Asia-Pacific Clinical Safety and Pharmacovigilance Services Market Size by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Clinical Safety and Pharmacovigilance Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Latin America Clinical Safety and Pharmacovigilance Services Market Size by Country (2019-2024) & (US$ Million)
 Table 42. Latin America Clinical Safety and Pharmacovigilance Services Market Size by Country (2025-2030) & (US$ Million)
 Table 43. Middle East & Africa Clinical Safety and Pharmacovigilance Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Middle East & Africa Clinical Safety and Pharmacovigilance Services Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Middle East & Africa Clinical Safety and Pharmacovigilance Services Market Size by Country (2025-2030) & (US$ Million)
 Table 46. SGS Company Details
 Table 47. SGS Business Overview
 Table 48. SGS Clinical Safety and Pharmacovigilance Services Product
 Table 49. SGS Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 50. SGS Recent Development
 Table 51. PPD Company Details
 Table 52. PPD Business Overview
 Table 53. PPD Clinical Safety and Pharmacovigilance Services Product
 Table 54. PPD Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 55. PPD Recent Development
 Table 56. ICON Company Details
 Table 57. ICON Business Overview
 Table 58. ICON Clinical Safety and Pharmacovigilance Services Product
 Table 59. ICON Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 60. ICON Recent Development
 Table 61. IQVIA Company Details
 Table 62. IQVIA Business Overview
 Table 63. IQVIA Clinical Safety and Pharmacovigilance Services Product
 Table 64. IQVIA Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 65. IQVIA Recent Development
 Table 66. Accenture Company Details
 Table 67. Accenture Business Overview
 Table 68. Accenture Clinical Safety and Pharmacovigilance Services Product
 Table 69. Accenture Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 70. Accenture Recent Development
 Table 71. Syneos Health Company Details
 Table 72. Syneos Health Business Overview
 Table 73. Syneos Health Clinical Safety and Pharmacovigilance Services Product
 Table 74. Syneos Health Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 75. Syneos Health Recent Development
 Table 76. Clarivate Company Details
 Table 77. Clarivate Business Overview
 Table 78. Clarivate Clinical Safety and Pharmacovigilance Services Product
 Table 79. Clarivate Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 80. Clarivate Recent Development
 Table 81. Wipro Company Details
 Table 82. Wipro Business Overview
 Table 83. Wipro Clinical Safety and Pharmacovigilance Services Product
 Table 84. Wipro Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 85. Wipro Recent Development
 Table 86. HCLTech Company Details
 Table 87. HCLTech Business Overview
 Table 88. HCLTech Clinical Safety and Pharmacovigilance Services Product
 Table 89. HCLTech Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 90. HCLTech Recent Development
 Table 91. Medpace Company Details
 Table 92. Medpace Business Overview
 Table 93. Medpace Clinical Safety and Pharmacovigilance Services Product
 Table 94. Medpace Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 95. Medpace Recent Development
 Table 96. ProPharma Company Details
 Table 97. ProPharma Business Overview
 Table 98. ProPharma Clinical Safety and Pharmacovigilance Services Product
 Table 99. ProPharma Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 100. ProPharma Recent Development
 Table 101. Lambda Therapeutic Research Company Details
 Table 102. Lambda Therapeutic Research Business Overview
 Table 103. Lambda Therapeutic Research Clinical Safety and Pharmacovigilance Services Product
 Table 104. Lambda Therapeutic Research Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 105. Lambda Therapeutic Research Recent Development
 Table 106. PVpharm Company Details
 Table 107. PVpharm Business Overview
 Table 108. PVpharm Clinical Safety and Pharmacovigilance Services Product
 Table 109. PVpharm Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 110. PVpharm Recent Development
 Table 111. George Clinical Company Details
 Table 112. George Clinical Business Overview
 Table 113. George Clinical Clinical Safety and Pharmacovigilance Services Product
 Table 114. George Clinical Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 115. George Clinical Recent Development
 Table 116. PharmaLex Company Details
 Table 117. PharmaLex Business Overview
 Table 118. PharmaLex Clinical Safety and Pharmacovigilance Services Product
 Table 119. PharmaLex Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 120. PharmaLex Recent Development
 Table 121. Parexel Company Details
 Table 122. Parexel Business Overview
 Table 123. Parexel Clinical Safety and Pharmacovigilance Services Product
 Table 124. Parexel Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 125. Parexel Recent Development
 Table 126. CTI Company Details
 Table 127. CTI Business Overview
 Table 128. CTI Clinical Safety and Pharmacovigilance Services Product
 Table 129. CTI Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 130. CTI Recent Development
 Table 131. UBC Company Details
 Table 132. UBC Business Overview
 Table 133. UBC Clinical Safety and Pharmacovigilance Services Product
 Table 134. UBC Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 135. UBC Recent Development
 Table 136. Biomapas Company Details
 Table 137. Biomapas Business Overview
 Table 138. Biomapas Clinical Safety and Pharmacovigilance Services Product
 Table 139. Biomapas Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 140. Biomapas Recent Development
 Table 141. Aixial Group Company Details
 Table 142. Aixial Group Business Overview
 Table 143. Aixial Group Clinical Safety and Pharmacovigilance Services Product
 Table 144. Aixial Group Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 145. Aixial Group Recent Development
 Table 146. Worldwide Clinical Trials Company Details
 Table 147. Worldwide Clinical Trials Business Overview
 Table 148. Worldwide Clinical Trials Clinical Safety and Pharmacovigilance Services Product
 Table 149. Worldwide Clinical Trials Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 150. Worldwide Clinical Trials Recent Development
 Table 151. Biotrial Company Details
 Table 152. Biotrial Business Overview
 Table 153. Biotrial Clinical Safety and Pharmacovigilance Services Product
 Table 154. Biotrial Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 155. Biotrial Recent Development
 Table 156. PrimeVigilance Company Details
 Table 157. PrimeVigilance Business Overview
 Table 158. PrimeVigilance Clinical Safety and Pharmacovigilance Services Product
 Table 159. PrimeVigilance Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 160. PrimeVigilance Recent Development
 Table 161. MMS Holdings Company Details
 Table 162. MMS Holdings Business Overview
 Table 163. MMS Holdings Clinical Safety and Pharmacovigilance Services Product
 Table 164. MMS Holdings Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 165. MMS Holdings Recent Development
 Table 166. TransPerfect Life Sciences Company Details
 Table 167. TransPerfect Life Sciences Business Overview
 Table 168. TransPerfect Life Sciences Clinical Safety and Pharmacovigilance Services Product
 Table 169. TransPerfect Life Sciences Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 170. TransPerfect Life Sciences Recent Development
 Table 171. Amarex Company Details
 Table 172. Amarex Business Overview
 Table 173. Amarex Clinical Safety and Pharmacovigilance Services Product
 Table 174. Amarex Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 175. Amarex Recent Development
 Table 176. Precision for Medicine Company Details
 Table 177. Precision for Medicine Business Overview
 Table 178. Precision for Medicine Clinical Safety and Pharmacovigilance Services Product
 Table 179. Precision for Medicine Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 180. Precision for Medicine Recent Development
 Table 181. Sitero Company Details
 Table 182. Sitero Business Overview
 Table 183. Sitero Clinical Safety and Pharmacovigilance Services Product
 Table 184. Sitero Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 185. Sitero Recent Development
 Table 186. Medfiles Company Details
 Table 187. Medfiles Business Overview
 Table 188. Medfiles Clinical Safety and Pharmacovigilance Services Product
 Table 189. Medfiles Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 190. Medfiles Recent Development
 Table 191. Arriello Company Details
 Table 192. Arriello Business Overview
 Table 193. Arriello Clinical Safety and Pharmacovigilance Services Product
 Table 194. Arriello Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 195. Arriello Recent Development
 Table 196. TFS HealthScience Company Details
 Table 197. TFS HealthScience Business Overview
 Table 198. TFS HealthScience Clinical Safety and Pharmacovigilance Services Product
 Table 199. TFS HealthScience Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 200. TFS HealthScience Recent Development
 Table 201. Pivotal Company Details
 Table 202. Pivotal Business Overview
 Table 203. Pivotal Clinical Safety and Pharmacovigilance Services Product
 Table 204. Pivotal Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 205. Pivotal Recent Development
 Table 206. Quanticate Company Details
 Table 207. Quanticate Business Overview
 Table 208. Quanticate Clinical Safety and Pharmacovigilance Services Product
 Table 209. Quanticate Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 210. Quanticate Recent Development
 Table 211. Veristat Company Details
 Table 212. Veristat Business Overview
 Table 213. Veristat Clinical Safety and Pharmacovigilance Services Product
 Table 214. Veristat Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 215. Veristat Recent Development
 Table 216. WuXi AppTec Company Details
 Table 217. WuXi AppTec Business Overview
 Table 218. WuXi AppTec Clinical Safety and Pharmacovigilance Services Product
 Table 219. WuXi AppTec Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 220. WuXi AppTec Recent Development
 Table 221. Tigermed Company Details
 Table 222. Tigermed Business Overview
 Table 223. Tigermed Clinical Safety and Pharmacovigilance Services Product
 Table 224. Tigermed Revenue in Clinical Safety and Pharmacovigilance Services Business (2019-2024) & (US$ Million)
 Table 225. Tigermed Recent Development
 Table 226. Research Programs/Design for This Report
 Table 227. Key Data Information from Secondary Sources
 Table 228. Key Data Information from Primary Sources
 Table 229. Authors List of This Report


List of Figures
 Figure 1. Clinical Safety and Pharmacovigilance Services Picture
 Figure 2. Global Clinical Safety and Pharmacovigilance Services Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Clinical Safety and Pharmacovigilance Services Market Share by Type: 2023 VS 2030
 Figure 4. Clinical Study Safety Services Features
 Figure 5. Post-Marketing Pharmacovigilance Services Features
 Figure 6. Global Clinical Safety and Pharmacovigilance Services Market Size by Application (2024-2030) & (US$ Million)
 Figure 7. Global Clinical Safety and Pharmacovigilance Services Market Share by Application: 2023 VS 2030
 Figure 8. Pharmaceutical Companies Case Studies
 Figure 9. Biotechnology Firms Case Studies
 Figure 10. Medical Device Manufacturers Case Studies
 Figure 11. Academic and Research Institutions Case Studies
 Figure 12. Others Case Studies
 Figure 13. Clinical Safety and Pharmacovigilance Services Report Years Considered
 Figure 14. Global Clinical Safety and Pharmacovigilance Services Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 15. Global Clinical Safety and Pharmacovigilance Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Clinical Safety and Pharmacovigilance Services Market Share by Region: 2023 VS 2030
 Figure 17. Global Clinical Safety and Pharmacovigilance Services Market Share by Players in 2023
 Figure 18. Global Top Clinical Safety and Pharmacovigilance Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Safety and Pharmacovigilance Services as of 2023)
 Figure 19. The Top 10 and 5 Players Market Share by Clinical Safety and Pharmacovigilance Services Revenue in 2023
 Figure 20. North America Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. North America Clinical Safety and Pharmacovigilance Services Market Share by Country (2019-2030)
 Figure 22. United States Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Canada Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Clinical Safety and Pharmacovigilance Services Market Share by Country (2019-2030)
 Figure 26. Germany Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Clinical Safety and Pharmacovigilance Services Market Share by Region (2019-2030)
 Figure 34. China Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Japan Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. South Korea Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Southeast Asia Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. India Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Australia Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Clinical Safety and Pharmacovigilance Services Market Share by Country (2019-2030)
 Figure 42. Mexico Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Brazil Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Clinical Safety and Pharmacovigilance Services Market Share by Country (2019-2030)
 Figure 46. Turkey Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Saudi Arabia Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. UAE Clinical Safety and Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. SGS Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 50. PPD Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 51. ICON Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 52. IQVIA Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 53. Accenture Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 54. Syneos Health Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 55. Clarivate Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 56. Wipro Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 57. HCLTech Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 58. Medpace Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 59. ProPharma Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 60. Lambda Therapeutic Research Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 61. PVpharm Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 62. George Clinical Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 63. PharmaLex Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 64. Parexel Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 65. CTI Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 66. UBC Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 67. Biomapas Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 68. Aixial Group Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 69. Worldwide Clinical Trials Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 70. Biotrial Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 71. PrimeVigilance Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 72. MMS Holdings Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 73. TransPerfect Life Sciences Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 74. Amarex Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 75. Precision for Medicine Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 76. Sitero Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 77. Medfiles Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 78. Arriello Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 79. TFS HealthScience Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 80. Pivotal Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 81. Quanticate Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 82. Veristat Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 83. WuXi AppTec Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 84. Tigermed Revenue Growth Rate in Clinical Safety and Pharmacovigilance Services Business (2019-2024)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure